Healthcare provider profile · identity verified

John W. Weaver, MD

Family Practice · HIGH POINT, NC · NPI 1154341311

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	922	266
Lisinopril	Lisinopril	645	190
Amlodipine Besylate	Amlodipine Besylate	534	158
Omeprazole	Omeprazole	458	122
Levothyroxine Sodium	Levothyroxine Sodium	434	110
Rosuvastatin Calcium	Rosuvastatin Calcium	411	115
Losartan Potassium	Losartan Potassium	367	108
Metformin Hcl	Metformin Hcl	278	81
Pravastatin Sodium	Pravastatin Sodium	260	69
Pantoprazole Sodium	Pantoprazole Sodium	242	69
Hydrochlorothiazide	Hydrochlorothiazide	233	72
Metoprolol Succinate	Metoprolol Succinate	209	65
Gabapentin	Gabapentin	195	65
Ezetimibe	Ezetimibe	191	56
Escitalopram Oxalate	Escitalopram Oxalate	156	45
Sertraline Hcl	Sertraline Hcl	151	43
Duloxetine Hcl	Duloxetine Hcl	145	34
Simvastatin	Simvastatin	145	43
Montelukast Sodium	Montelukast Sodium	142	40
Tizanidine Hcl	Tizanidine Hcl	129	54
Alendronate Sodium	Alendronate Sodium	128	33
Celecoxib	Celecoxib	128	39
Valsartan	Valsartan	127	42
Metoprolol Tartrate	Metoprolol Tartrate	123	27
Januvia	Sitagliptin Phosphate	120	25
Potassium Chloride	Potassium Chloride	119	28
Pioglitazone Hcl	Pioglitazone Hcl	103	33
Citalopram Hbr	Citalopram Hydrobromide	99	23
Trazodone Hcl	Trazodone Hcl	98	26
Furosemide	Furosemide	94	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	92	26
Allopurinol	Allopurinol	85	24
Glimepiride	Glimepiride	84	23
Jardiance	Empagliflozin	81	20
Fluticasone Propionate	Fluticasone Propionate	78	29
Albuterol Sulfate Hfa	Albuterol Sulfate	77	29
Zolpidem Tartrate	Zolpidem Tartrate	76	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	18
Alprazolam	Alprazolam	73	11
Tamsulosin Hcl	Tamsulosin Hcl	71	19
Tramadol Hcl	Tramadol Hcl	66	14
Diclofenac Sodium	Diclofenac Sodium	61	23
Fluoxetine Hcl	Fluoxetine Hcl	61	18
Carvedilol	Carvedilol	60	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	13
Fenofibrate	Fenofibrate	60	20
Glipizide Er	Glipizide	56	17
Meloxicam	Meloxicam	56	20
Atenolol	Atenolol	54	15
Benazepril Hcl	Benazepril Hcl	53	12
Glipizide	Glipizide	53	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	13
Farxiga	Dapagliflozin Propanediol	51	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	49	11
Synthroid	Levothyroxine Sodium	48	11
Clopidogrel	Clopidogrel Bisulfate	47	13
Azelastine Hcl	Azelastine Hcl	45	27
Eliquis	Apixaban	44	suppressed
Ozempic	Semaglutide	44	suppressed
Famotidine	Famotidine	42	15
Prednisone	Prednisone	41	30
Clonazepam	Clonazepam	39	suppressed
Lorazepam	Lorazepam	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Bupropion Hcl Sr	Bupropion Hcl	37	16
Bupropion Xl	Bupropion Hcl	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	35
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Ramipril	Ramipril	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Lovastatin	Lovastatin	32	11
Mupirocin	Mupirocin	32	26
Repatha Sureclick	Evolocumab	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	28
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	30	suppressed
Metformin Hcl Er	Metformin Hcl	29	11
Clonidine Hcl	Clonidine Hcl	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Belsomra	Suvorexant	24	suppressed
Finasteride	Finasteride	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Diazepam	Diazepam	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	11
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	14
Estradiol	Estradiol	17	suppressed
Fluconazole	Fluconazole	17	11
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nadolol	Nadolol	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Letrozole	Letrozole	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Temazepam	Temazepam	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error